Cargando…
Pim1 kinase is required to maintain tumorigenicity in MYC-expressing prostate cancer cells
PIM1 kinase and MYC are commonly co-expressed in human prostate cancer and synergize to induce rapidly progressing prostate cancer in mouse models. Deficiency of the Pim kinase genes is well tolerated in vivo, suggesting that PIM1 inhibition might offer an attractive therapeutic modality for prostat...
Autores principales: | Wang, Jie, Anderson, Philip D., Luo, Weifeng, Gius, David, Roh, Meejeon, Abdulkadir, Sarki A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3223544/ https://www.ncbi.nlm.nih.gov/pubmed/21860423 http://dx.doi.org/10.1038/onc.2011.371 |
Ejemplares similares
-
Pim1 promotes human prostate cancer cell tumorigenicity and c-MYC transcriptional activity
por: Kim, Jongchan, et al.
Publicado: (2010) -
Pim1 kinase synergizes with c-MYC to induce advanced prostate carcinoma
por: Wang, Jie, et al.
Publicado: (2010) -
A Role for Polyploidy in the Tumorigenicity of Pim-1-Expressing Human Prostate and Mammary Epithelial Cells
por: Roh, Meejeon, et al.
Publicado: (2008) -
Interactions between Cells with Distinct Mutations in c-MYC and Pten in Prostate Cancer
por: Kim, Jongchan, et al.
Publicado: (2009) -
A mouse model of heterogeneous, c-MYC-initiated prostate cancer with loss of Pten and p53
por: Kim, Jongchan, et al.
Publicado: (2011)